Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblasts
Zhite Zhao(Xijing Hospital), Changhong Shi(Air Force Medical University), Tong Lü(Xijing Hospital), Xinglin He(Xijing Hospital), Yifan Ma(Nantong University), Hui Li(University of Maryland, Baltimore), Mengyao Li(Air Force Medical University), Lijun Yang(Xijing Hospital), Yaohua Hu(Shanghai Aerospace Automobile Electromechanical (China)), Minli Huang(Air Force Medical University)
Cited by 13
Related Papers
Review on near-infrared heptamethine cyanine dyes as theranostic agents for tumor imaging, targeting, and photodynamic therapy
|Journal of Biomedical Optics|2016|273
T Cell Membrane Mimicking Nanoparticles with Bioorthogonal Targeting and Immune Recognition for Enhanced Photothermal Therapy
|Advanced Science|2019|208
Association of body mass index, physical activity, and reproductive histories with breast cancer: a case-control study in Gifu, Japan
|Breast Cancer Research and Treatment|1997|93
Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer
|Nature Medicine|2018|83
Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and suppresses cellular immune functions in colon cancer
|Cancer Immunology Immunotherapy|2020|71